US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AdvisorShares Psychedelics ETF

24.32

-0.1800-0.73%

Post-market: 23.97-0.3500-1.44%19:56 EDT

Volume:25.81K

Turnover:629.58K

Market Cap:56.42M

PE:- -

High:24.66

Open:24.66

Low:24.14

Close:24.50

52wk High:27.02

52wk Low:15.63

Shares:2.32M

Float Shares:2.32M

Volume Ratio:0.54

T/O Rate:1.11%

Dividend:1.71

Dividend Rate:7.01%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Alkermes Plc : TD Cowen Raises Target Price to $58 from $57

THOMSON REUTERS

Alkermes Plc : Baird Raises Target Price to $58 from $48

THOMSON REUTERS

Lakes Blue Energy Highlights Exploration Risks in Capital Raising Brief

Lakes Blue Energy launches $8.7m capital raising and reshapes board

Acrow shareholders back capital raisings at extraordinary meeting

Vita Resources Ends Oakley Capital Mandate as It Resets Funding Strategy

Wall Street Analysts Are Bullish on Top Healthcare Picks

Alkermes Price Target Raised to $65.00/Share from $43.00 by Piper Sandler

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Alkermes (ALKS) and Universal Health (UHS)

Alkermes Plc Reports Results for the Quarter Ended June 30 - Earnings Summary

Alkermes Releases Transcript of Q2 2026 Earnings Call

Alkermes sinks 5% to $50.05 following Q2 report

Relmada Therapeutics Names Bipin Dalmia Chief Business Officer

Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer

THOMSON REUTERS

Alkermes Q2 Earnings Flat, Revenue Rises; Reiterates 2026 Revenue Guidance

MT Newswires Live

Atea Pharmaceuticals reports C-BEYOND trial meets primary, secondary endpoints

Alkermes Q2 Sales $496.009M Beat $457.818M Estimate

Benzinga Earnings

Press Release: Alkermes Plc Reports Second Quarter 2026 Financial Results

Alkermes Plc : Piper Sandler Raises Target Price to $65 from $43

THOMSON REUTERS

Greenvale Energy Plans Major Share and Option Issue to Boost Capital Base

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/PSIL/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PSIL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","market":"US","secType":"STK","nameCN":"AdvisorShares Psychedelics ETF","latestPrice":24.32,"timestamp":1789588800000,"preClose":24.5,"halted":0,"volume":25811,"hourTrading":{"tag":"盘后","latestPrice":23.97,"preClose":24.32,"latestTime":"19:56 EDT","volume":1038,"amount":24919.4073,"timestamp":1789603002316,"change":-0.35,"changeRate":-0.014391,"amplitude":0.014391},"delay":0,"changeRate":-0.007346938775510192,"floatShares":2319976,"shares":2319976,"eps":0,"marketStatus":"Not Yet Opened","change":-0.18,"latestTime":"09-16 16:00:00 EDT","open":24.66,"high":24.66,"low":24.14,"amount":629579.3309,"amplitude":0.021224,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789632000000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":24.5,"sharesOutstanding":1184976,"nav":24.374,"aum":56546897.05,"dividendRate":0.070115,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":25.06,"preClose":24.5,"latestTime":"08:44 EDT","volume":39,"amount":972.7199820000001,"timestamp":1789562657590,"change":0.56,"changeRate":0.022857,"amplitude":0.039592},"postHourTrading":{"tag":"盘后","latestPrice":23.97,"preClose":24.32,"latestTime":"19:56 EDT","volume":1038,"amount":24919.4073,"timestamp":1789603002316,"change":-0.35,"changeRate":-0.014391,"amplitude":0.014391},"volumeRatio":0.538481,"impliedVol":0.5167,"impliedVolPercentile":0.8645},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","floatShares":2319976,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.538481,"shares":2319976,"dividePrice":1.7052,"high":24.66,"amplitude":0.021224,"preClose":24.5,"low":24.14,"week52Low":15.6348,"pbRate":"--","week52High":27.0175,"institutionHeld":0,"latestPrice":24.32,"eps":0,"divideRate":0.070115,"volume":25811,"delay":0,"ttmEps":0,"open":24.66,"prevYearClose":17.17,"prevWeekClose":24.7682,"prevMonthClose":24.62,"prevQuarterClose":24.05,"fiveDayClose":25.21,"twentyDayClose":26.2,"sixtyDayClose":21.35},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PSIL\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PSIL","amount":1.68387,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2025-09-22","symbol":"PSIL","amount":0.02007,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-29","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-29"},{"date":"2025-06-23","symbol":"PSIL","amount":0.01191,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"},{"date":"2025-03-21","symbol":"PSIL","amount":0.16343,"announcedDate":"2025-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-21","defaultRemindTime":1742563800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-21","currency":"USD","dateTimestamp":1742529600000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"PSIL","amount":0.05477,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-30","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PSIL\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-26","recordDate":"2022-09-27","paymentDate":"2022-09-30","value":0.05421,"currency":"USD"},{"executeDate":"2023-09-25","recordDate":"2023-09-26","paymentDate":"2023-09-29","value":0.00336,"currency":"USD"},{"executeDate":"2024-09-23","recordDate":"2024-09-23","paymentDate":"2024-09-30","value":0.1087,"currency":"USD"},{"executeDate":"2024-12-23","recordDate":"2024-12-23","paymentDate":"2024-12-30","value":0.05477,"currency":"USD"},{"executeDate":"2025-03-21","recordDate":"2025-03-21","paymentDate":"2025-03-28","value":0.16343,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PSIL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PSIL\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2655855711","title":"Alkermes Plc : TD Cowen Raises Target Price to $58 from $57","url":"https://stock-news.laohu8.com/highlight/detail?id=2655855711","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655855711?lang=en_us&edition=fundamental","pubTime":"2026-07-29 13:22","pubTimestamp":1785302541,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43V0HB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALKS","PSIL","FBT","PSCH","BK4139","MEDX","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655853939","title":"Alkermes Plc : Baird Raises Target Price to $58 from $48","url":"https://stock-news.laohu8.com/highlight/detail?id=2655853939","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655853939?lang=en_us&edition=fundamental","pubTime":"2026-07-29 12:22","pubTimestamp":1785298959,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43V062:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRN","MEDX","PSCH","FBT","ALKS","BK4139","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655581578","title":"Lakes Blue Energy Highlights Exploration Risks in Capital Raising Brief","url":"https://stock-news.laohu8.com/highlight/detail?id=2655581578","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655581578?lang=en_us&edition=fundamental","pubTime":"2026-07-29 11:37","pubTimestamp":1785296243,"startTime":"0","endTime":"0","summary":"Lakes Blue Energy NL ( ($AU:LKO) ) has issued an announcement. Lakes Blue Energy NL has released a capital raising presentation outlining its curre...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lakes-blue-energy-highlights-exploration-risks-in-capital-raising-brief?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lakes-blue-energy-highlights-exploration-risks-in-capital-raising-brief?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655858154","title":"Lakes Blue Energy launches $8.7m capital raising and reshapes board","url":"https://stock-news.laohu8.com/highlight/detail?id=2655858154","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655858154?lang=en_us&edition=fundamental","pubTime":"2026-07-29 11:37","pubTimestamp":1785296235,"startTime":"0","endTime":"0","summary":"The latest update is out from Lakes Blue Energy NL ( ($AU:LKO) ). Lakes Blue Energy NL has completed a $4.0 million placement and launched a partia...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lakes-blue-energy-launches-8-7m-capital-raising-and-reshapes-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lakes-blue-energy-launches-8-7m-capital-raising-and-reshapes-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655485884","title":"Acrow shareholders back capital raisings at extraordinary meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2655485884","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655485884?lang=en_us&edition=fundamental","pubTime":"2026-07-29 10:52","pubTimestamp":1785293562,"startTime":"0","endTime":"0","summary":"Acrow Formwork and Construction Services Limited ( ($AU:ACF) ) just unveiled an announcement. Acrow Limited has reported that shareholders at its 2...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/acrow-shareholders-back-capital-raisings-at-extraordinary-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/acrow-shareholders-back-capital-raisings-at-extraordinary-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655836622","title":"Vita Resources Ends Oakley Capital Mandate as It Resets Funding Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2655836622","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655836622?lang=en_us&edition=fundamental","pubTime":"2026-07-29 06:28","pubTimestamp":1785277692,"startTime":"0","endTime":"0","summary":"An announcement from Bastion Minerals Ltd ( ($AU:VTA) ) is now available. Vita Resources NL has terminated its capital raising mandate with Oakley ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vita-resources-ends-oakley-capital-mandate-as-it-resets-funding-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vita-resources-ends-oakley-capital-mandate-as-it-resets-funding-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655884804","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2655884804","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655884804?lang=en_us&edition=fundamental","pubTime":"2026-07-29 02:00","pubTimestamp":1785261615,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alkermes (ALKS) and Incyte (INCY) with bullish senti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-264?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-264?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSCH","ALKS","PSIL","INCY","BK4588","BK4550","IBRN","BK4585","FBT","IDNA","MEDX","BK4139","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655264886","title":"Alkermes Price Target Raised to $65.00/Share from $43.00 by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2655264886","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655264886?lang=en_us&edition=fundamental","pubTime":"2026-07-29 00:10","pubTimestamp":1785255000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALKS/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBT","PSIL","BK4139","PSCH","IBRN","ALKS","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654424888","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Alkermes (ALKS) and Universal Health (UHS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2654424888","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654424888?lang=en_us&edition=fundamental","pubTime":"2026-07-28 22:20","pubTimestamp":1785248424,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alkermes (ALKS) and Universal Health (UHS). Alkermes (ALKS) Needh...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-alkermes-alks-and-universal-health-uhs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-alkermes-alks-and-universal-health-uhs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALKS","UHS","BK4588","MEDX","BK4137","LABU","BK4581","BK4185","XBI","IBRN","PSCH","BK4585","BK4139","HCSG","FBT","PSIL","LU0029874061.USD","LU0128526141.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654700086","title":"Alkermes Plc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2654700086","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654700086?lang=en_us&edition=fundamental","pubTime":"2026-07-28 21:32","pubTimestamp":1785245569,"startTime":"0","endTime":"0","summary":"Alkermes Plc reports results for the quarter ended June 30 - Earnings SummaryAlkermes PlcALKS.OQreported quarterly breakeven results per share for the quarter ended June 30, lower than the same quarte","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nL8N43U1WO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","PSCH","BK4139","IBRN","PSIL","ALKS","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654071550","title":"Alkermes Releases Transcript of Q2 2026 Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2654071550","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654071550?lang=en_us&edition=fundamental","pubTime":"2026-07-28 21:17","pubTimestamp":1785244649,"startTime":"0","endTime":"0","summary":"Alkermes releases transcript of Q2 2026 earnings callAlkermes discussed Q2 2026 results on an earnings call attended by CEO Richard Pops, CFO Joshua Reed, CCO Todd Nichols, COO and incoming CEO Blair ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDL35dZmZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBT","BK4139","IBRN","ALKS","PSIL","PSCH","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654007833","title":"Alkermes sinks 5% to $50.05 following Q2 report","url":"https://stock-news.laohu8.com/highlight/detail?id=2654007833","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654007833?lang=en_us&edition=fundamental","pubTime":"2026-07-28 20:50","pubTimestamp":1785243027,"startTime":"0","endTime":"0","summary":"08:45 EDT Alkermes (ALKS) sinks 5% to $50.05 following Q2 report Published first on TheFly – the ultimate source for real-time, market-moving break...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alkermes-sinks-5-to-50-05-following-q2-report-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alkermes-sinks-5-to-50-05-following-q2-report-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ALKS","IBRN","MEDX","PSCH","FBT","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654047370","title":"Relmada Therapeutics Names Bipin Dalmia Chief Business Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2654047370","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654047370?lang=en_us&edition=fundamental","pubTime":"2026-07-28 20:30","pubTimestamp":1785241852,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics names Bipin Dalmia chief business officerRelmada named Bipin Dalmia as chief business officer, leading corporate strategy, commercial planning, business development; reporting to ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDLFbB7t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","LU2210150020.SGD","IE00BKPKM429.USD","IE00BN0W2W23.USD","NDAQ","BCDF","IE00BN0W2V16.EUR","SG9999014013.SGD","LU2095319765.USD","BK4588","IE00B64PRP62.GBP","IE00BGHQF748.EUR","BK4007","LU2210149790.SGD","SG9999014005.SGD","SG9999014021.USD","SG9999014039.USD","BK4585","BK4112","LU0314104364.USD","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","RLMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654004205","title":"Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2654004205","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654004205?lang=en_us&edition=fundamental","pubTime":"2026-07-28 20:30","pubTimestamp":1785241801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nTUA1ZDKJ2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","BK4007","RLMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654100907","title":"Alkermes Q2 Earnings Flat, Revenue Rises; Reiterates 2026 Revenue Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2654100907","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654100907?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:42","pubTimestamp":1785238953,"startTime":"0","endTime":"0","summary":"Alkermes  reported break-even earnings for Q2 Tuesday, compared with earnings of $0.52 per share a year earlier.Analysts polled by FactSet expected a loss of $0.03.Total revenue for the quarter ended June 30 was $496 million, up from $390.7 million a year earlier.Analysts surveyed by FactSet expected $457.4 million.For 2026, Alkermes reiterated its total revenue guidance of $1.73 billion to $1.84 billion. Analysts polled by FactSet expected $1.81 billion.Shares of the company were up less than 1% in recent Tuesday premarket activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALKS","PSIL","PSCH","FBT","BK4139","MEDX","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654009645","title":"Atea Pharmaceuticals reports C-BEYOND trial meets primary, secondary endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2654009645","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654009645?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:21","pubTimestamp":1785237677,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals (AVIR) announced topline results from C-BEYOND, its Phase 3 trial conducted in North America evaluating the once-daily fixed-d...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/atea-pharmaceuticals-reports-c-beyond-trial-meets-primary-secondary-endpoints-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/atea-pharmaceuticals-reports-c-beyond-trial-meets-primary-secondary-endpoints-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","PSIL","BK4007","AVIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654006162","title":"Alkermes Q2 Sales $496.009M Beat $457.818M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2654006162","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654006162?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:02","pubTimestamp":1785236572,"startTime":"0","endTime":"0","summary":"Alkermes (NASDAQ:ALKS) reported quarterly sales of $496.009 million which beat the analyst consensus estimate of $457.818 million by 8.34 percent.  This is a 26.97 percent increase over sales of $390.657 million the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/07/60719288/alkermes-q2-sales-496-009m-beat-457-818m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALKS","IBRN","MEDX","PSCH","FBT","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654006923","title":"Press Release: Alkermes Plc Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2654006923","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654006923?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:00","pubTimestamp":1785236400,"startTime":"0","endTime":"0","summary":"DUBLIN--(BUSINESS WIRE)--July 28, 2026--Alkermes plc (Nasdaq: ALKS) today reported financial results for the quarter ended June 30, 2026. To view the detailed second quarter 2026 earnings press releas","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSCH","PSIL","IBRN","MEDX","ALKS","FBT","BK4139","ADHD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654502005","title":"Alkermes Plc : Piper Sandler Raises Target Price to $65 from $43","url":"https://stock-news.laohu8.com/highlight/detail?id=2654502005","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654502005?lang=en_us&edition=fundamental","pubTime":"2026-07-28 12:05","pubTimestamp":1785211555,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nFWN43T1LE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","BK4139","PSCH","ALKS","IBRN","MEDX","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654002919","title":"Greenvale Energy Plans Major Share and Option Issue to Boost Capital Base","url":"https://stock-news.laohu8.com/highlight/detail?id=2654002919","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654002919?lang=en_us&edition=fundamental","pubTime":"2026-07-28 07:50","pubTimestamp":1785196211,"startTime":"0","endTime":"0","summary":"Greenvale Mining ( ($AU:GRV) ) has provided an update. Greenvale Energy Ltd has notified the ASX of a proposed capital raising via a placement and ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/greenvale-energy-plans-major-share-and-option-issue-to-boost-capital-base?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/greenvale-energy-plans-major-share-and-option-issue-to-boost-capital-base?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}